BIOTINA · MD1003CT2016-01MS-SPI2

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

Effects of MD1003 in progressive multiple sclerosis: a randomized, double-blind, placebo-controlled study. EudraCT: 2016-000700-29

Sponsor: MEDDAY PHARMA

Phase: III

Area: Neuroimmunology

Open the current study catalogue